June 20, 2025

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 50% Potential Upside Despite Challenges

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector, specializes in molecular diagnostics and precision medicine. The company is renowned for its comprehensive..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 224% Upside Potential in the Biotech Arena

Inventiva S.A. (IVA), a French biopharmaceutical company, is attracting investor attention with its ambitious research pipeline and the tantalizing possibility of a substantial upside. As a..

Altimmune, Inc. (ALT) Stock Analysis: A 203% Potential Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has captured the attention of investors with a staggering potential upside of 203.18%, according to analyst ratings. Specializing..

Autolus Therapeutics (AUTL) Stock Analysis: A Biotech Gem with 378% Upside Potential

Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling case for investors seeking opportunities in the biotechnology sector, particularly those with a focus on innovative cancer therapies...

Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a 299% Potential Upside in the Biotechnology Sector

In the dynamic world of biotechnology, Humacyte, Inc. (NASDAQ: HUMA) stands out as a promising player with its cutting-edge approach to bioengineered human tissues. With a..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Unveiling a 43% Potential Upside for Biotech Investors

Investors with a keen interest in the biotechnology sector might find Verve Therapeutics, Inc. (NASDAQ: VERV) an intriguing prospect. Specializing in gene editing therapies for cardiovascular..

Valneva SE (VALN) Investor Outlook: Exploring a 133.68% Potential Upside in the Biotech Sector

Valneva SE (NASDAQ: VALN) is a French biotechnology company that has garnered significant attention from investors due to its promising vaccine portfolio and potential for substantial..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Uncovering a Remarkable 255% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing the attention of investors with an intriguing proposition in the healthcare sector, particularly within the biotechnology industry. Specializing in..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Remarkable 161% Potential Upside in Biotech

Investors with a keen eye on the biotechnology sector may want to take a closer look at Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Eyeing an 89.79% Potential Upside in Healthcare Innovation

Castle Biosciences, Inc. (NASDAQ: CSTL) stands at the forefront of the molecular diagnostics industry, specializing in innovative solutions for dermatologic cancers and other critical health conditions...

LENZ Therapeutics, Inc. (LENZ): Investor Outlook on a Biotech with 48% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biopharmaceutical industry, stands out with its promising therapies aimed at improving vision. Headquartered in Solana Beach,..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a Potential 161% Upside for Investors

AxoGen, Inc. (NASDAQ: AXGN), a pioneering entity in the medical devices sector, is garnering significant attention from investors due to its promising growth trajectory and substantial..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unveiling 11.66% Potential Upside for Investors

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves within the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $618.01 million,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 30.6% Potential Upside with Analyst Insights

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a key player in the healthcare staffing industry, offers a compelling narrative for investors seeking opportunities within the healthcare sector...

Claritev Corporation (CTEV) Stock Analysis: Navigating the Healthcare Data Landscape Amidst a 52-Week High

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services industry, has captured investor attention with its innovative approach to cost management and data..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a Promising 54% Upside Potential

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company based in Warminster, Pennsylvania, is catching the attention of investors with a compelling potential upside of 54.43%...

Regulus Therapeutics Inc. (RGLS) Stock Analysis: A Biotech with 7.19% Upside Potential

Regulus Therapeutics Inc. (NASDAQ: RGLS) presents an intriguing proposition for investors seeking opportunities in the biotechnology sector. With its current market cap of $568.41 million, Regulus..

Personalis, Inc. (PSNL) Stock Analysis: Riding the Wave of Genomic Innovation with 7.20% Upside Potential

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector, specifically within the diagnostics and research industry, has been making waves with its innovative approaches..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 315.82% Upside in the Biotech Arena

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is garnering significant attention in the biotechnology sector, primarily due to its innovative approach in developing therapies targeting G protein-coupled receptors..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth and Challenges in Senior Care

Sonida Senior Living, Inc. (SNDA) operates within the healthcare sector, specifically focusing on medical care facilities. Based in Dallas, Texas, this company provides essential services for..

Search

Funds

June 20, 2025

Search

Funds

June 20, 2025

FTSE 100

Funds